OrthoAccel Technologies appoints new board member
May 14, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing OrthoAccel Technologies, len hedge
US-based medical device firm OrthoAccel Technologies has announced that Len Hedge has joined its board of directors. Hedge currently serves on the …
UK doctors urged to curb overtreatment
May 13, 2015Sales and Marketing Academy of Medical Royal Colleges, BMJ, NHS, uk doctors
The UK’s body of medical colleges has launched a new campaign to warn of the dangers of over-treating patients with …
AstraZeneca makes a move into precision medicine
May 13, 2015Research and Development, Sales and Marketing AstraZeneca, Precision Medicine, cardiovascular diseases, diabetes, mhi
AstraZeneca has signalled its intention to ramp up the use of personalised medicine strategies to find new candidate drugs and …
Baxter buys cancer portfolio for $900 million
May 13, 2015Research and Development, Sales and Marketing Cancer, Oncaspar, Sigma-Tau Finanziaria, baxter, oncology
Baxter is buying leukaemia treatment Oncaspar from Italian firm Sigma-Tau Finanziaria for $900 million as the US firm looks to …
Applied Proteomics hires commercial VP
May 13, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Applied Proteomics, Erwin Estigarribia
San Diego’s Applied Proteomics that develops protein-based molecular diagnostics has confirmed the appointment of Erwin Estigarribia as the VP of …
Scottish Medicines Consortium approves seven drugs
May 12, 2015Sales and Marketing NHS, SMC, Scottish Medicines Consortium
The Scottish Medicines Consortium has accepted seven new medicines and indications for use on the NHS in Scotland. Two of …
Pharma reveals its ASCO presentation data
May 12, 2015Research and Development, Sales and Marketing ASCO, AZ, AbbVie, Roche, chicago, data
AstraZeneca, Genentech and AbbVie have all revealed which cancer drugs they will show data for at The American Society of …
Pharma M&A trail continues as Pfizer buys slice of Dutch biotech
May 12, 2015Sales and Marketing Endo, Pfizer, aspen, merger
Pfizer has acquired a minority equity interest in the biotech firm AM-Pharma, and secured an exclusive option to acquire the …
Alexion plans big expansion in Ireland
May 12, 2015Manufacturing and Production, Sales and Marketing Alexion, Dublin, Ireland, soliris
Alexion Pharmaceuticals is significantly expanding its operations in Ireland by building the US firm’s first ever biologics manufacturing facility outside …
New chief financial officer for Shire
May 12, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Shire, jeff poulton
Irish pharma firm Shire has appointed a new chief financial officer and member of its executive committee in Jeff Poulton. …
Takeda announces new cancer collaboration
May 11, 2015Research and Development, Sales and Marketing Cancer, Europe, Takeda, mental health, ncc
Takeda will be teaming up with Japan’s National Cancer Center (NCC) to develop new cancer drugs. The two organisations have …
GSK launches new HIV research centre
May 11, 2015Research and Development, Sales and Marketing AIDS, GSK, HIV, UNC-Chapel Hill, ViiV, qura
GlaxoSmithKline is boosting its philanthropic efforts in R&D into HIV/AIDS by teaming up with academic researchers to launch a new …
Novartis invests further into Poland
May 11, 2015Manufacturing and Production, Sales and Marketing Novartis, Poland, Sandoz, manufacturing, packaging
Sandoz the generics division of Novartis has opened a large packaging centre in Stryków in Poland. Valued at 171 million …
Ariad founder retires
May 11, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ariad, harvey Berger
Dr Harvey Berger the founder of US pharma firm Ariad Pharmaceuticals has announced his decision to retire as chairman and …
Reputation gains from focussing on the patient
May 11, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, HIV, Manuel Goncalves, Pfizer, ViiV
Since being spun-off from GSK and Pfizer, specialist HIV firm ViiV Healthcare has earned the best corporate reputation amongst patients …
Merck to test Keytruda combinations
May 8, 2015Sales and Marketing BMS, Daiichi Sankyo, Merck, Plexxikon, keytruda, pembrolizumab
Merck will be teaming up with Daiichi Sankyo’s subsidiary Plexxikon to investigate immunotherapy combinations in cancer. A collaborative clinical trial …
US Court blocks Novartis biosimilar Neupogen
May 8, 2015Sales and Marketing Neupogen, Novartis, Zarxio, biosimilar, filagrastim, filgrastim-sndz
Novartis have been temporarily prevented from marketing its biosimilar version of Amgen’s drug Neupogen in the US. Earlier this year …
New malaria vaccine found effective in adults
May 8, 2015Research and Development, Sales and Marketing Oxford, Plasmodium falciparum, Vaccine, malaria
A new malaria vaccine has shown promise in early stage trials, reducing the risk of contracting the disease by two …
Boardroom shuffles at GSK and Roche
May 8, 2015Medical Communications, Sales and Marketing GSK, Novartis, Roche, ViiV, changes, leadership
GlaxoSmithKline and Roche have announced the latest changes to its leadership teams as the companies regroup for the year ahead. …
New app can aid tropical disease treatment
May 8, 2015Medical Communications, Sales and Marketing Merck, app, smartphone, tropical diseases
A new smartphone app is able to automatically detect parasites in the blood and may mark a fundamental shift in …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
